Clinical Trial Update: Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 trial studying temsirolimus added to standard chemotherapy in patients over 60 with acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Temsirolimus (temsirolimus)

Snippet

Sponsor: Goethe University | Conditions: Acute Myeloblastic Leukemia | Phase 2 | Status: COMPLETED